• Registration Under Way for Pulmonary Fibrosis Foundation Summit
  • British Researchers Develop One-Hour Flu and Viral Infections Test
  • Heartburn Therapy May Not Be Effective or Safe for IPF Patients on Esbriet
  • Boehringer Ingelheim Phase 3 Trial Evaluates Ofev in Patients with Progressive Fibrosing Interstitial Lung Disease
  • FDA Agrees with ProMetic’s Protocol for PBI-4050 in IPF Clinical Trials
  • Bristol-Myers, Nordic Partnering on Development of Biomarkers for Fibrotic Diseases
  • MURDOCK Study Aims to Determine Real-World Impact of COPD
  • NuMedii and Three Lakes Partners Collaborate to Discover New Therapies for IPF
  • Researchers Develop New Probe to Follow PF Progression, Treatment
  • Researchers Review Performance of Genentech’s Esbriet in Treating Idiopathic Pulmonary Fibrosis
  • Pulmonary Fibrosis Forces Tough Decisions as the Disease Progresses
  • Positive Trial Data Evaluating Anabasum to Treat CF Announced by Corbus

Pulmonary Fibrosis

Asthma

Bronchiectasis

BRONCHIOLITIS

CHRONIC BRONCHITIS

COPD

 CYSTIC FIBROSIS

EMPHYSEMA

IDIOPATHIC PULMONARY FIBROSIS

LUNG CANCER

PNEUMONIA

PULMONARY HYPERTENSION

SCLERODERMA